Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19323612 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.
Condition: Acute Bacterial Conjunctivitis
Interventions: Drug: ISV-403;   Drug: Vehicle

Indicates status has not been verified in more than two years